29.06.2017

Construction of a new shop for the production of finished medicines will start at the site of the enterprise JSC Exon in Drogichin, the product will meet all the requirements of good manufacturing practices (GMP).

The production is designed for the manufacture of drugs in the form of tablets, capsules, troches, suspensions, emulsions, aerosols. It is planed to produce coated tablets are alone up to 12,760 per year. 40 jobs will be created.

tabletki-sust-3.jpg

Prospects for the implementation of this investment project were discussed at the meeting in Minsk by the leadership of the Ministry of Health, representatives of the Tianjin Electric Power Company of the China Energy Group Corporation, the head of the Exon JSC and Belalek Group.

"In the medium term, for the purposes of import substitution, the sale of the products is expected in the domestic market," said Igor Stoma, director of the pharmaceutical company Belalek Group. By 2021, we expect to occupy at least 25% of the domestic market of manufactured products. According to calculations, the share of exports should be up to 38% by 2027. "

The result of the meeting was the signing of the general contract agreement by director of JSC Belalek Group Igor Stoma and Director General of the Tianjin Electric Power Company of the Chinese Energy Group Corporation Mr. Jinping.

According to minzdrav.gov.by